Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053557/0568 | |
| Pages: | 9 |
| | Recorded: | 08/21/2020 | | |
| Attorney Dkt #: | SHE0324 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/21/2015
|
Application #:
|
13823953
|
Filing Dt:
|
09/04/2013
|
|
Publication #:
|
|
Pub Dt:
|
02/05/2015
| | | | |
|
Title:
|
CRYSTALLINE NALOXOL-PEG CONJUGATE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/06/2015
|
Application #:
|
14645347
|
Filing Dt:
|
03/11/2015
|
|
Publication #:
|
|
Pub Dt:
|
10/08/2015
| | | | |
|
Title:
|
CRYSTALLINE NALOXOL-PEG CONJUGATE
|
|
|
Assignee
|
|
|
|
|
| 455 MISSION BAY BOULEVARD SOUTH |
| SUITE 100 |
| SAN FRANCISCO, CALIFORNIA 94158 |
|
|
Correspondence name and address
|
| |
NEKTAR THERAPEUTICS
|
| |
455 MISSION BAY BOULEVARD SOUTH
|
| |
SUITE 100
|
| |
SAN FRANCISCO, CA 94158
|
Search Results as of:
06/24/2025 05:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
